Cargando…

Commentary: Gene Therapy: A Promising Approach for Neuroprotection in Parkinson's Disease?

Detalles Bibliográficos
Autor principal:	Segura-Aguilar, Juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437110/ https://www.ncbi.nlm.nih.gov/pubmed/28579947 http://dx.doi.org/10.3389/fnana.2017.00040

Ejemplares similares

Gene Therapy: A Promising Approach for Neuroprotection in Parkinson’s Disease?
por: Valdés, Pamela, et al.
Publicado: (2016)

The Promise of Neuroprotective Agents in Parkinson’s Disease
por: Seidl, Stacey E., et al.
Publicado: (2011)

Erratum: The promise of neuroprotective agents in Parkinson's disease
por: Seidl, Stacey E., et al.
Publicado: (2013)

On the role of endogenous neurotoxins and neuroprotection in Parkinson's disease
por: Segura-Aguilar, Juan
Publicado: (2017)

Commentary: Evaluation of Models of Parkinson's Disease
por: Muñoz, Patricia, et al.
Publicado: (2016)

Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs
por: Naqvi, Saba, et al.
Publicado: (2020)

Corrigendum: Commentary: Evaluation of Models of Parkinson's Disease
por: Muñoz, Patricia, et al.
Publicado: (2016)

Glutamic Acid Transporters: Targets for Neuroprotective Therapies in Parkinson’s Disease
por: Li, Xiang, et al.
Publicado: (2021)

Ginseng: a promising neuroprotective strategy in stroke
por: Rastogi, Vaibhav, et al.
Publicado: (2015)

On the Role of Aminochrome in Mitochondrial Dysfunction and Endoplasmic Reticulum Stress in Parkinson's Disease
por: Segura-Aguilar, Juan
Publicado: (2019)

Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection
por: More, Sandeep Vasant, et al.
Publicado: (2015)

Aminochrome Induces Irreversible Mitochondrial Dysfunction by Inducing Autophagy Dysfunction in Parkinson's Disease
por: Segura-Aguilar, Juan, et al.
Publicado: (2018)

On the Right Track to Treat Movement Disorders: Promising Therapeutic Approaches for Parkinson’s and Huntington’s Disease
por: Troncoso-Escudero, Paulina, et al.
Publicado: (2020)

Exercise-Induced Neuroprotection of the Nigrostriatal Dopamine System in Parkinson's Disease
por: Hou, Lijuan, et al.
Publicado: (2017)

Riboflavin Has Neuroprotective Potential: Focus on Parkinson’s Disease and Migraine
por: Marashly, Eyad T., et al.
Publicado: (2017)

The Emerging Role of Energy Metabolism and Neuroprotective Strategies in Parkinson's Disease
por: Błaszczyk, Janusz W.
Publicado: (2018)

Parkinson’s Disease: Can Targeting Inflammation Be an Effective Neuroprotective Strategy?
por: Gundersen, Vidar
Publicado: (2021)

Commentary: A Humanized Clinically Calibrated Quantitative Systems Pharmacology Model for Hypokinetic Motor Symptoms in Parkinson's Disease
por: Muñoz, Patricia, et al.
Publicado: (2016)

c-Abl Inhibitors Enable Insights into the Pathophysiology and Neuroprotection in Parkinson’s Disease
por: Lindholm, Dan, et al.
Publicado: (2016)

Catalpol Exerts a Neuroprotective Effect in the MPTP Mouse Model of Parkinson’s Disease
por: Wang, Li-Yuan, et al.
Publicado: (2019)

Melatonin: a promising neuroprotective agent for cerebral ischemia-reperfusion injury
por: Tozihi, Majid, et al.
Publicado: (2023)

Commentary: Clinical Correlates of Raphe Serotonergic Dysfunction in Early Parkinson’s Disease
por: Liguori, Claudio, et al.
Publicado: (2015)

Orexin-A Exerts Neuroprotective Effects via OX1R in Parkinson’s Disease
por: Liu, Mei-Fang, et al.
Publicado: (2018)

Commentary: Discriminating α-synuclein strains in parkinson's disease and multiple system atrophy
por: Fellner, Lisa, et al.
Publicado: (2020)

Promising Metabolite Profiles in the Plasma and CSF of Early Clinical Parkinson's Disease
por: Stoessel, Daniel, et al.
Publicado: (2018)

Fisetin Regulates Gut Microbiota and Exerts Neuroprotective Effect on Mouse Model of Parkinson’s Disease
por: Chen, Tian-Jiao, et al.
Publicado: (2020)

The neuroprotective effects of glucagon-like peptide 1 in Alzheimer’s and Parkinson’s disease: An in-depth review
por: Reich, Niklas, et al.
Publicado: (2022)

Triglyceride Form of Docosahexaenoic Acid Mediates Neuroprotection in Experimental Parkinsonism
por: Gómez-Soler, Maricel, et al.
Publicado: (2018)

Retinoic acid-loaded polymeric nanoparticles induce neuroprotection in a mouse model for Parkinson's disease
por: Esteves, Marta, et al.
Publicado: (2015)

Decreased soluble Nogo-B in serum as a promising biomarker for Parkinson's disease
por: Liang, Hongming, et al.
Publicado: (2022)

Commentary: Roles of the Cannabinoid System in the Basal Ganglia in Parkinson's Disease
por: Oikonomou, Panteleimon, et al.
Publicado: (2022)

Lactoferrin: neuroprotection against Parkinson's disease and secondary molecule for potential treatment
por: Eker, Furkan, et al.
Publicado: (2023)

Editorial: Neuroprotection in Brain Hypoxia
por: Otero-Losada, Matilde, et al.
Publicado: (2019)

Evaluating rehabilitation interventions in Parkinson's disease with functional MRI: a promising neuroprotective strategy
por: Mallio, Carlo Augusto, et al.
Publicado: (2015)

Current Experimental Studies of Gene Therapy in Parkinson's Disease
por: Lin, Jing-ya, et al.
Publicado: (2017)

Commentary on: “Motor Switching and Motor Adaptation Deficits Contribute to Freezing of Gait in Parkinson’s Disease”
por: Thibaudier, Yann
Publicado: (2015)

A commentary on: “A 12-year population-based study of freezing of gait in Parkinson's disease”
por: Crouse, Jacob J., et al.
Publicado: (2015)

From the bench to the bedside: Emerging science in Parkinson’s disease, cholesterol metabolism, and neuroprotection
por: Hauptman, Jason S.
Publicado: (2010)

Neuroprotective and therapeutic effects of calcitriol in rotenone-induced Parkinson’s disease rat model
por: Magdy, Alshimaa, et al.
Publicado: (2022)

Long-Term Continuous Cervical Spinal Cord Stimulation Exerts Neuroprotective Effects in Experimental Parkinson’s Disease
por: Kuwahara, Ken, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_peihekoutpq3qbj5fg6eut2nl6